InhaleRx (ASX:IRX) Days Sales Outstanding : 0.00 (As of Jun. 2023)

View and export this data going back to 2017. Start your Free Trial

What is InhaleRx Days Sales Outstanding?

InhaleRx's average Accounts Receivable for the six months ended in Jun. 2023 was A$0.26 Mil. InhaleRx's Revenue for the six months ended in Jun. 2023 was A$0.00 Mil.

The historical rank and industry rank for InhaleRx's Days Sales Outstanding or its related term are showing as below:

During the past 7 years, InhaleRx's highest Days Sales Outstanding was 467.20. The lowest was 87.03. And the median was 155.93.

ASX:IRX's Days Sales Outstanding is not ranked ^*
in the Medical Devices & Instruments industry.
Industry Median: 64.21
* Ranked among companies with meaningful Days Sales Outstanding only.

InhaleRx's Days Sales Outstanding stayed the same from Jun. 2022 (0.00) to Jun. 2023 (0.00).

InhaleRx Days Sales Outstanding Historical Data

The historical data trend for InhaleRx's Days Sales Outstanding can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

InhaleRx Days Sales Outstanding Chart

InhaleRx Annual Data

Trend

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Days Sales Outstanding

Get a 7-Day Free Trial

209.68

467.20

InhaleRx Semi-Annual Data
	Jun17	Dec17	Jun18	Dec18	Jun19	Dec19	Jun20	Dec20	Jun21	Dec21	Jun22	Dec22	Jun23	Dec23
Days Sales Outstanding	Get a 7-Day Free Trial									-	-	-	-	-

Competitive Comparison of InhaleRx's Days Sales Outstanding

For the Medical Devices subindustry, InhaleRx's Days Sales Outstanding, along with its competitors' market caps and Days Sales Outstanding data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

InhaleRx's Days Sales Outstanding Distribution in the Medical Devices & Instruments Industry

For the Medical Devices & Instruments industry and Healthcare sector, InhaleRx's Days Sales Outstanding distribution charts can be found below:

* The bar in red indicates where InhaleRx's Days Sales Outstanding falls into.

InhaleRx Days Sales Outstanding Calculation

Days Sales Outstanding measures the average number of days that a company takes to collect revenue after a sale has been made. It is a financial ratio that illustrates how well a company's Accounts Receivable are being managed.

Accounts Receivable can be measured by Days Sales Outstanding.

InhaleRx's Days Sales Outstanding for the fiscal year that ended in Dec. 2023 is calculated as

	Days Sales Outstanding (A: Dec. 2023 )
=	Average Accounts Receivable					/	Revenue	*	Days in Period
=	( (Accounts Receivable (A: Dec. 2022 )	+	Accounts Receivable (A: Dec. 2023 ))	/	count )	/	Revenue (A: Dec. 2023 )	*	Days in Period
=	( (0.032	+	0)	/	1 )	/	0	*	365
=	0.032					/	0	*	365
=	N/A

InhaleRx's Days Sales Outstanding for the quarter that ended in Jun. 2023 is calculated as:

	Days Sales Outstanding (Q: Jun. 2023 )
=	Average Accounts Receivable					/	Revenue	*	Days in Period
=	( (Accounts Receivable (A: Dec. 2022 )	+	Accounts Receivable (A: Jun. 2023 ))	/	count )	/	Revenue (A: Jun. 2023 )	*	Days in Period
=	( (0.032	+	0.492)	/	2 )	/	0	*	365 / 2
=	0.262					/	0	*	365 / 2
=	N/A

InhaleRx (ASX:IRX) Days Sales Outstanding Explanation

For retailers, when we compare Days Sales Outstanding, it is important to compare the same period in the previous years.

InhaleRx Days Sales Outstanding Related Terms

Thank you for viewing the detailed overview of InhaleRx's Days Sales Outstanding provided by GuruFocus.com. Please click on the following links to see related term pages.

InhaleRx (ASX:IRX) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » InhaleRx Ltd (ASX:IRX) » Definitions » Days Sales Outstanding

Comparable Companies

Traded in Other Exchanges

N/A

Address

126 Phillip Street, Level 5, Sydney, NSW, AUS, 2000

Website

https://www.inhalerx.com.au

InhaleRx Ltd focuses on medical inhalation devices for the delivery of prescribed medicines. The Medihale Inhaler utilizes heat (not burn) technology, avoiding the production of pyrolytic toxins and carcinogenic often created when combusting plant material such as tobacco or cannabis leaves of flowers. The sealed tamper-proof Medihale Pods provide patients with the additional security that the Medical Cannabis c-liquid is of good quality.

InhaleRx (ASX:IRX) Headlines

No Headlines